Dr. Vijay Gorantla is currently an Associate Professor of Surgery in the Department of Plastic Surgery and the Administrative Medical Director of the Pittsburgh Reconstructive Transplant Program at University of Pittsburgh Medical Center (UPMC) as well as a Deputy Director at the McGowan Institute.
Dr. Gorantla received his medical degree from the University of Health Sciences in India and pursued clinical training at King George Hospital. He completed postgraduate surgical training in Manchester, United Kingdom, followed by post-doctoral fellowships in microsurgery and plastic and reconstructive surgery at the University of Louisville and in hand surgery at the Christine M. Kleinert Institute for Hand and Microsurgery, Kentucky. He also earned a Masters and a PhD from the University of Louisville focused on the transplantation immunology of vascularized composite allografts (VCA). He played a key role in the Nationís first hand transplant program at the University of Louisville before being recruited by UPMC. At UPMC, his efforts were fundamental to the institutional approval, federal funding, and establishment of the Nationís second upper extremity transplant program. In 2008, at the Veterans Affairs Pittsburgh Healthcare System (VAPHS) he helped gain approval for the Nationís first Upper Extremity Transplant Program at a Transplant VA Center. He was appointed as Director of the VAPHS Program in 2010.
Dr. Gorantlaís specific training and background involves reconstructive transplantation (limb, face, and other structures) after civilian or combat trauma. His academic interests include but are not limited to translational and clinical aspects of immunomodulation (stem cell therapies, immunobiologics), neuroregeneration (neurobiologics) and targeted therapeutic, monitoring or diagnostic strategies in VCA (local immunosuppression, gene therapy, immunosurveillance, non-invasive molecular/multimodality imaging of rejection, ex vivo preservation techniques, immunocloaking, and immunoevasion in donor grafts).
Dr. Gorantla is the Principal Investigator at the University of Pittsburgh on multiple translational and clinical studies funded by the department of defense (DOD). As an established DOD-funded investigator, over the last decade, Dr. Gorantla has been actively engaged in convergent technologies in the restoration or rehabilitation of disabilities secondary to complex limb loss, traumatic brain injury, or vision loss. Recently, in collaboration with Carnegie Mellon University, he was awarded a $1.2 M clinical trial award from the DOD to study the use of Videoenabled High Resolution Ultrasound for non-invasive monitoring of chronic graft vasculopathy and nerve regeneration in upper extremity transplantation. In collaboration with Harvard University (Dr. Larry Benowitz) and Stanford University (Dr. Jeffrey Goldberg), he is the lead investigator on a $1 M multi-site partnership grant from the DOD CDMRP Vision Research Program to study novel neurotherapeutic strategies in whole eyeball transplantation. The overarching goal of this research is to restore vision following devastating damage to the eye and/or optic nerve.
Dr. Gorantla is Deputy Director, Clinical Initiatives and Research Innovation at the McGowan Institute and the Center for Military Medicine Research at the University of Pittsburgh. He also serves as consultant for Reconstructive Transplantation at the San Antonio Military Medical Center and the Lackland Air Force Base (59th Medical Wing). His goal is to stimulate civilian-military research networks between academia, industry, and military partners to promote successful treatment and repair of battlefield injuries via development of comprehensive, collaborative research, and clinical opportunities. He is tasked with identifying disruptive or transformative strategies incorporating regenerative medicine, tissue engineering, nanotechnology, computational biology, predictive analytics, or other multi- or cross-disciplinary integration to address the critical needs of service men and women as well as civilians with traumatic injuries.
Dr. Gorantla is founding member and elected board member of the American Society for Reconstructive Transplantation. He is council member on the International Hand and Composite Tissue Allotransplantation Society. He serves on the OPTN/UNOS Membership and Professional Standards Committee (MPSC) and has also been elected to the Leadership and Innovation Council at the Organ Donation and Transplantation Alliance. He is member of the Transplantation Society, American Society of Reconstructive Microsurgery, World Society for Reconstructive Microsurgery, the American Society of Transplantation, the Plastic Surgery Research Council, and the Kleinert Society. Dr. Gorantla has a Masterís in Medical Management (MMM) [Healthcare MBA] from the highly ranked Carnegie Mellon Universityís Heinz School of Management. His interests include healthcare innovation as focused on e-health, telemedicine, precision medicine, pharmacogenomics, population health, and predictive analytics to improve health related quality of life outcomes.
View a list of Dr. Gorantlaís publications here.
Vijay S. Gorantla, MD, PhD
Media Requests Ė Please contact Rick Pietzak, phone: (412) 864-4151